Trials / Unknown
UnknownNCT05347381
Selinexol Combined With Dexamethasone in the Treatment of CAEBV
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 14 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-center, prospective, observational clinical study to evaluate the Effecive and Safty of Selinexol and Dexamethasone in CAEBV
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Selinexol and Dexamethasone | Selinesol 20mg/tablet 60mg po qw first week, second week, biw third week, namely d1, d8, d15, d18. Dexamethasone 0.75mg/tablet 1.5mg po bid d1-21; |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2022-04-26
- Last updated
- 2022-04-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05347381. Inclusion in this directory is not an endorsement.